Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

7.100 +0.150 (+2.16%)

Delayed Quote Updated: 2:28 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Earnings Outlook For Emergent BioSolutions ↗

February 24, 2023

Via Benzinga

Emergent BioSolutions (EBS) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

EBS earnings call for the period ending September 30, 2022.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 16, 2023

Via Benzinga

Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

February 16, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 16, 2023

It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 15, 2023

Via Benzinga

Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines ↗

February 15, 2023

Via Benzinga

February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More ↗

January 31, 2023

The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...

Via Benzinga

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot ↗

January 13, 2023

Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 18, 2022

On Friday, 64 companies achieved new lows for the year.

Via Benzinga

EXCLUSIVE: SAB Biotherapeutics Posts Wider Quarterly Loss, Cash Runway Expected Into Mid-2023 ↗

November 15, 2022

SAB Biotherapeutics' (NASDAQ: SABS) Q3 net loss reached $(7.1) million, equivalent to an EPS loss of $(0.16), as compared to a net loss of $(4.1) million a year ago. Cash and cash equivalents were $8.3...

Via Benzinga

Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals ↗

November 14, 2022

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 09, 2022

Gainers

Via Benzinga

'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target ↗

November 09, 2022

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing ↗

November 09, 2022

Biotech stocks were hammered Wednesday, including several that had good news.

Via Investor's Business Daily

MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday ↗

November 09, 2022

Via Benzinga

Ranking the 7 Top Small-Cap Stocks to Buy From Best to Worst ↗

October 24, 2022

Although blue chips provide greater predictability, these top small-cap stocks to buy may drive intense growth for speculators.

Via InvestorPlace

Emergent Shares Decline Following Commencement Of Initial-Stage Lassa Virus Vaccine Candidate Study ↗

September 06, 2022

Emergent BioSolutions (NYSE: EBS) has dosed first patient in its Phase 1 study evaluating the safety and immunogenicity of EBS-LASV in healthy subjects. EBS-LASV is a recombinant VSV-vectored Lassa...

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

3 Top Monkeypox Stocks to Buy Right Now ↗

August 24, 2022

With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.

Via InvestorPlace

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗

August 23, 2022

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.

Via Benzinga

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗

August 19, 2022

Via Benzinga

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗

August 18, 2022

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.

Via Benzinga

WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant ↗

August 18, 2022

Via Benzinga

A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring ↗

August 17, 2022

Blue Water Vaccines Inc (NASDAQ: BWV)

Via Benzinga

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.